The Antibodies, Next-Generation Proteins & Bioconjugates is dedicated to Driving creative protein engineering & design to successfully transform promising new molecules.
Key Topics
Designing bi- and multi-specifics with novel modes of action
Increasing efficacy, potency, selectivity, and payload capacity
Improving developability and drug-like properties
Discovering new pathways for immunotherapies
Achieving delivery into cells and across the blood-brain barrier
Engineering breakthroughs across diverse disease indications
Developing CAR T therapies and immunotherapies
Utilizing gene editing technologies for protein engineering and design
Achieving delivery into cells and across the blood-brain barrier
Applying new technologies for challenging targets
Identifying new targets beyond oncology
Applying novel chemistries for conjugation and linker payload technologies
Decreasing attrition rates in the clinic for bioconjugates
Overcoming bioconjugate development challenges
Who should Attend
Attendees with job titles such as:
Director (Associate, Senior, Executive)
Vice President
Chief Scientific Officer
Scientist (Associate, Lead, Senior, Principal)
Group Leader
Engineer (Development, Principal)
Laboratory Manager/Head
Investigator/Principal Investigator
Fellow
Manager
(Senior) Research Fellow
Project Leader
Team Leader
Senior Researcher
Technical Specialist
From departments:
Antibody Engineering
Antibody Discovery
Bioanalytical Sciences
Antibody Research
Bioengineering
Biochemistry
Cell Biology
Biotherapeutics R&D
Computational Design
Engineering (Chemical, Molecular)
Drug Discovery
Discovery
Immunology (Preclinical, Clinical)
Immunogenicity
Oncology
Molecular (Biology, Sciences)
Peptides and Peptide Chemistry
Cancer Research
Protein Analytics Protein Analytical Development
Pharmaceutical Sciences
Protein (Design, Discovery, Engineering, Expression)
Please, check "Antibodies, Next-Generation Proteins Therapeutics Summit" official website for possible changes, before making any traveling arrangements
